Table 1.
Descriptive information for children in the study sample
| Glucocorticoid Treatment Group (N = 18) | Comparison Group (N = 36) | |
|---|---|---|
| Gestational age at birth (weeks) | 38.5 (1.1) | 39.0 (1.0) |
| Range: 37.1 – 41.3 | Range: 37.0 – 41.3 | |
| Birth weight (grams) | 3410 (392.8) | 3358 (447.3) |
| Range: 2896 - 4561 | Range: 2280 - 4490 | |
| Sex (% female) | 56 | 56 |
| Apgar score at 5-minutes | 8.8 (0.5) | 8.9 (0.5) |
| Range: 7 - 9 | Range: 7 - 10 | |
| Race/Ethnicity (%) | ||
| Hispanic | 39 | 53 |
| Non-Hispanic White | 28 | 28 |
| African American | 6 | 6 |
| Multi-ethnic | 28 | 14 |
| Child Age at MRI (years) | 8.5 (1.3) | 8.1 (1.1) |
| Range: 6.3 – 10.4 | Range: 6.1 – 10.5 | |
| GA at first dose (weeks) | 29.3 (3.2) | N/A |
| Range: 23.7 – 34.1 | ||
| Days between first dose and delivery | 65.1 (21.5) | N/A |
| Range: 29 - 107 | ||
| Received tocolytics prenatally (%) | 94% | 0% |
| Birth order (% firstborn) | 39 | 19 |
| Total grey matter volume (cc) | 668609 | 660740 |
| Affective Problems T-score | 52.4 (3.2) | 53.9 (4.4) |